RNase H-based assays utilizing modified RNA monomers
US-9644198-B2 · May 9, 2017 · US
US11873480B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11873480-B2 |
| Application number | US-201515519482-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 16, 2015 |
| Priority date | Oct 17, 2014 |
| Publication date | Jan 16, 2024 |
| Grant date | Jan 16, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments provided herein relate to methods and compositions for preparing an immobilized library of barcoded DNA fragments of a target nucleic acid, identifying genomic variants, determining the contiguity information, phasing information, and methylation status of the target nucleic acid.
Opening claim text (preview).
What is claimed is: 1. A method of preparing a library of barcoded DNA fragments of a target DNA comprising: a. binding a target DNA to a plurality of transposome complexes, each transposome complex comprising transposons and transposases, wherein the transposons comprise transferred strands and non-transferred strands, and wherein at least one of the transposons of the transposome complex comprises an adaptor sequence capable of hybridizing to a complementary capture sequence; b. fragmenting the target DNA of step a into a plurality of contiguously-linked, transposed DNA fragments and inserting a plurality of transferred strands into at least one strand of each contiguously-linked transposed DNA fragment of the plurality of contiguously-linked transposed fragments, wherein contiguity of DNA fragments of the target DNA is maintained by the transposases; c. immobilizing the plurality of contiguously-linked, transposed DNA fragments of step b on a plurality of solid supports by hybridizing the adaptor sequence of the at least one of the transposons to a complementary capture sequence, each of the solid supports in the plurality comprising a plurality of immobilized oligonucleotides, each oligonucleotide of the plurality of immobilized oligonucleotides comprising, in sequential order extending from a surface of the solid support: (i) a first primer binding site attached to the solid support; (ii) a first barcode sequence; and (iii) a complementary capture sequence capable of hybridizing to the adaptor sequence; and d. attaching the first barcode sequence to one or more of the plurality of contiguously-linked, transposed DNA fragments of step c, thereby producing a library of barcoded, linked DNA fragments, wherein the first barcode sequences of all of the oligonucleotides of the plurality of oligonucleotides immobilized on a given solid support comprise the same nucleic acid sequence, wherein a nucleic acid sequence of the first barcode sequence of the oligonucleotides of the plurality of oligonucleotides immobilized on a given solid support in the plurality of the solid supports differs from a nucleic acid sequence of all of the first barcode sequences from other solid supports in the plurality of solid supports, and wherein the steps (a)-(d) are carried out in a single reaction compartment. 2. The method of claim 1 , further comprising: e. determining the sequences of the contiguously-linked, transposed DNA fragments and the first barcode sequences; and f. determining contiguity information of the target DNA by identifying the first barcode sequences. 3. The method of claim 1 , further comprising: e. subjecting the contiguously-linked, transposed DNA fragments comprising the first barcodes to bisulfite treatment, thereby generating bisulfite treated target DNA fragments comprising barcodes; f. determining the sequence of the bisulfite treated contiguously-linked, transposed DNA fragments and the first barcode sequences; and g. determining the contiguity information of the target DNA by identifying the first barcode sequences, wherein the sequence information is indicative of the methylation status of the target DNA and the contiguity information is indicative of the haplotype information. 4. The method of claim 1 , wherein the attaching of the first barcode sequences to the contiguously-linked, transposed DNA fragments is by: (a) ligation; (b) polymerase extension; or (c) both ligation and polymerase extension. 5. The method of claim 4 , wherein the polymerase extension is by extending the 3 ′-end of the non-ligated transposon strand with a DNA polymerase using the ligated immobilized oligonucleotide as a template. 6. The method of claim 1 , wherein at least a portion of the adaptor sequences further comprise a second barcode sequence. 7. The method of claim 1 , wherein the transposome complexes are multimeric, and wherein the adaptor sequences of the transposons of each monomeric unit are different from the other monomeric unit in the same transposome complex. 8. The method of claim 1 , wherein the adaptor sequence further comprises a first primer binding sequence. 9. The method of claim 8 , wherein the first primer binding site has no sequence homology to the capture sequence or to the complement of the capture sequence. 10. The method of claim 1 , wherein the immobilized oligonucleotides on the solid support further comprise a second primer binding sequence. 11. The method of claim 1 , wherein the transposome complexes are multimeric, and wherein: (a) the transposome monomeric units are linked to each other in the same transposome complex; (b) the transposase of a transposome monomeric unit is linked to another transposase of another transposome monomeric unit of the same transposome complex; or (c) the transposons of a transposome monomeric unit are linked to transposons of another transposome monomeric unit of the same transposome complex. 12. The method of claim 1 , wherein the contiguity information of a target DNA sequence is indicative of haplotype information or is indicative of genomic variants or genome assembly. 13. The method of claim 12 , wherein the genomic variants are selected from the group consisting of deletions, translocations, interchromosomal gene fusions, duplications, and paralogs. 14. The method of claim 1 , wherein each oligonucleotide of the plurality of oligonucleotides immobilized on the plurality of solid supports comprises a partially double-stranded region and a partially single-stranded region. 15. The method of claim 14 , wherein the partially single-stranded regions of the plurality of immobilized oligonucleotides comprise a second barcode sequence and a second primer binding site. 16. The method of claim 2 , wherein the contiguously-linked, transposed DNA fragments comprising the first barcode sequences are amplified prior to determining the sequences of the target DNA fragments. 17. The method of claim 16 , wherein a third barcode sequence is introduced to the contiguously-linked, transposed DNA fragments during the amplification. 18. The method of claim 1 , wherein the target DNA is from a single cell, or is from a single organelle, or is genomic DNA, or is cross-linked to other nucleic acids, or is cell-free tumor DNA, or is cell-free tumor DNA obtained from placental fluid, or is cell-free tumor DNA obtained from plasma, or is cDNA, or is from a formalin-fixed, paraffin-embedded tissue sample, or is histone-protected DNA. 19. The method of claim 18 , wherein the target DNA is cell-free tumor DNA obtained from plasma, and the plasma is collected from whole blood using a membrane separator comprising a collection zone for the plasma. 20. The method of claim 19 , wherein the collection zone for the plasma comprises transposome complexes immobilized on solid support. 21. The method of claim 1 , wherein the solid support is a bead. 22. The method of claim 1 , wherein fragments of the library of barcoded, linked DNA fragments are amplified. 23. The method of claim 22 , wherein steps (a)-(d) and the amplification are both carried out in a single reaction compartment.
Biochemical methods, e.g. using enzymes or whole viable microorganisms · CPC title
Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes · CPC title
Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title
Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title
Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.